|
NUCKS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74105174721717E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.04281036531029E-13 |
| Normal-vs-Stage2 |
1.73156999999646E-05 |
| Normal-vs-Stage3 |
9.42759981192864E-10 |
| Normal-vs-Stage4 |
1.40030000039815E-07 |
| Stage1-vs-Stage2 |
3.002400E-01 |
| Stage1-vs-Stage3 |
8.988000E-01 |
| Stage1-vs-Stage4 |
9.738800E-01 |
| Stage2-vs-Stage3 |
4.149400E-01 |
| Stage2-vs-Stage4 |
4.511200E-01 |
| Stage3-vs-Stage4 |
9.555200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-14 |
| Normal-vs-AfricanAmerican |
1.114030E-01 |
| Normal-vs-Asian |
2.40580000365753E-09 |
| Caucasian-vs-AfricanAmerican |
1.074040E-02 |
| Caucasian-vs-Asian |
8.694000E-01 |
| AfricanAmerican-vs-Asian |
1.205710E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.39309708003088E-11 |
| Normal-vs-Female |
2.90434343241941E-12 |
| Male-vs-Female |
6.375400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.56104035148519E-12 |
| Normal-vs-Age(41-60Yrs) |
1.66799907219684E-11 |
| Normal-vs-Age(61-80Yrs) |
3.22480000036762E-07 |
| Normal-vs-Age(81-100Yrs) |
6.119100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.511200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.295190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.154000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.507400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.339600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.404800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.181500E-03 |
| Classical-VS-Follicular |
9.754600E-01 |
| Classical-VS-Other |
1.024220E-01 |
| Classical-VS-Normal |
4.3019032780478E-11 |
| Tall-VS-Follicular |
2.404400E-02 |
| Tall-VS-Other |
5.480400E-01 |
| Tall-VS-Normal |
4.19050016908784E-10 |
| Follicular-VS-Other |
1.266820E-01 |
| Follicular-VS-Normal |
9.20830000028516E-08 |
| Other-VS-Normal |
3.168100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.68651808868981E-12 |
| Normal-vs-N1 |
4.02899935636469E-11 |
| N0-vs-N1 |
9.683600E-02 |
|
|
